In a report released today, Miki Sogi from Bernstein maintained a Buy rating on Astellas Pharma (ALPMF – Research Report), with a price target ...

Karen Lewis (JO:LEWJ), the Chief People Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.75 billion market cap ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently executed a stock transaction involving the sale of company shares. According to a filing with ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

WILMINGTON, Mass., Jan. 22, 2025 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ: ADI) today announced the appointment of Andrea F. Wainer, a seasoned healthcare executive, to its Board of Directors as ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...